Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02630186
Title A Phase 1b/2 Study of Safety and Efficacy of Rociletinib in Combination With MPDL3280A in Patients With Advanced or Metastatic EGFR-mutant NSCLC
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Clovis Oncology, Inc.

lung non-small cell carcinoma


Atezolizumab + Rociletinib

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
University of California at Los Angeles Santa Monica California 90404 United States Details
*Shaded cells indicate that there was no data available from for the field